1. Home
  2. TNDM vs IBTA Comparison

TNDM vs IBTA Comparison

Compare TNDM & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNDM
  • IBTA
  • Stock Information
  • Founded
  • TNDM 2006
  • IBTA 2011
  • Country
  • TNDM United States
  • IBTA United States
  • Employees
  • TNDM N/A
  • IBTA N/A
  • Industry
  • TNDM Medical/Dental Instruments
  • IBTA
  • Sector
  • TNDM Health Care
  • IBTA
  • Exchange
  • TNDM Nasdaq
  • IBTA Nasdaq
  • Market Cap
  • TNDM 1.1B
  • IBTA 1.1B
  • IPO Year
  • TNDM 2013
  • IBTA 2024
  • Fundamental
  • Price
  • TNDM $15.59
  • IBTA $36.97
  • Analyst Decision
  • TNDM Buy
  • IBTA Buy
  • Analyst Count
  • TNDM 13
  • IBTA 10
  • Target Price
  • TNDM $32.15
  • IBTA $74.60
  • AVG Volume (30 Days)
  • TNDM 1.6M
  • IBTA 370.5K
  • Earning Date
  • TNDM 08-06-2025
  • IBTA 08-12-2025
  • Dividend Yield
  • TNDM N/A
  • IBTA N/A
  • EPS Growth
  • TNDM N/A
  • IBTA 24.66
  • EPS
  • TNDM N/A
  • IBTA 2.03
  • Revenue
  • TNDM $982,951,000.00
  • IBTA $369,501,000.00
  • Revenue This Year
  • TNDM $8.91
  • IBTA $6.89
  • Revenue Next Year
  • TNDM $11.04
  • IBTA $15.55
  • P/E Ratio
  • TNDM N/A
  • IBTA $18.30
  • Revenue Growth
  • TNDM 27.65
  • IBTA 7.20
  • 52 Week Low
  • TNDM $15.17
  • IBTA $31.40
  • 52 Week High
  • TNDM $48.24
  • IBTA $79.80
  • Technical
  • Relative Strength Index (RSI)
  • TNDM 27.20
  • IBTA N/A
  • Support Level
  • TNDM $15.17
  • IBTA N/A
  • Resistance Level
  • TNDM $17.12
  • IBTA N/A
  • Average True Range (ATR)
  • TNDM 0.99
  • IBTA 0.00
  • MACD
  • TNDM -0.31
  • IBTA 0.00
  • Stochastic Oscillator
  • TNDM 6.99
  • IBTA 0.00

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

About IBTA Ibotta Inc. Class A Common Stock

Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).

Share on Social Networks: